NAGE · Niagen Bioscience, Inc. · Proposed Sales
Market Cap
$242.01M
Shares
79.13M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
Key facts
CIK
1386570
CUSIP
171077407
13F (30d)
88 filings
88 filers
Visit website
Investor relations